Clinical Trials Logo
  1. Home
  2. Cardiomyopathy, Dilated
  3. NCT02352129

Prognostic Value of Myocardial Fibrosis Quantified Using CMR in Patient With Dilated Cardiomyopathy

Cardiomyopathy, Dilated Clinical Trial

Official title:
Prognostic Value of Myocardial Fibrosis Quantified Using CMR in Patient With Dilated Cardiomyopathy

Clinical Trial Summary

: Fibrosis, in general, is a scarring process, which is characterized by fibroblast accumulation and excess deposition of extracellular matrix (ECM) proteins, which leads to distorted organ architecture and function. The contribution of fibrogenesis to impaired cardiac function is increasingly recognized. The fibrotic ECM causes increased stiffness and induces pathological signaling within cardiomyocytes resulting in progressive cardiac failure. Also, the excessive ECM impairs mechano-electric coupling of cardiomyocytes and increases the risk of arrhythmias. But today patient treatment and prognosis is based on ejection fraction quantification, QRS duration, and symptoms. Hypothesis: the increased level of fibrosis quantified using T1 mapping technique, compared with normal value, is of prognostic value in patient with dilated cardiomyopathies under optimal treatment. Methods: 330 patients are planned to be included and followed for 2 years

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02352129
Study type Interventional
Source Assistance Publique Hopitaux De Marseille
Contact
Status Completed
Phase N/A
Start date December 2011
Completion date June 2017
View Details
See also
  Status Clinical Trial Phase
Active, not recruiting NCT03560167 - Early Feasibility Study of the AccuCinch® Ventricular Restoration System in Patients With Prior Mitral Valve Intervention (PMVI) and Recurrent Mitral Regurgitation N/A
Terminated NCT00624520 - Mental Stress Reduction in Defibrillator Patients Phase 3
Completed NCT00549861 - Characterization of Irreversible Myocardial Injury in Cardiomyopathies by Contrast-enhanced CMR N/A
Terminated NCT04222101 - Association of Insulin Resistance and FGF21 on Cardiac Function in Pediatric Dilated Cardiomyopathy N/A
Not yet recruiting NCT02517814 - Vitamin D Supplementation Can Improve Heart Function in Idiopathic Cardiomyopathy N/A
Completed NCT01391507 - Pilot Study of COR-1 in Heart Failure Phase 2
Completed NCT01940081 - The Leiden Nonischemic Cardiomyopathy Study
Completed NCT01181414 - Spanish Atrial Fibrillation And Resynchronization Study Phase 4
Not yet recruiting NCT06091475 - Therapy to Maintain Remission in Dilated Cardiomyopathy N/A
Recruiting NCT03340675 - Oral Ifetroban in Subjects With Duchenne Muscular Dystrophy Phase 2
Recruiting NCT05981092 - A Study About the Natural History in Adults With BAG3 Dilated Cardiomyopathy (a Type of Heart Disease)
Not yet recruiting NCT06039072 - Clinical Observation of Long-term Cardiac Function Prognosis in Patients With PPCM Who Have Recovered Cardiac Function
Recruiting NCT03910725 - Electrophysiological Phenotyping Of Patients at Risk of Ventricular Arrhythmia and Sudden Cardiac Death
Terminated NCT01478087 - Immunoadsorption Therapy for Patients With Non-Ischemic Dilated Cardiomyopathy (DCM) N/A
Recruiting NCT00221780 - Role of Left Ventricular Pacing Site N/A
Terminated NCT02958098 - My Research Legacy Pilot Study
Completed NCT00123071 - Variability of Ventricular Mass, Volume, & Ejection Fraction in Pediatric Cardiomyopathy Patients-Pediatric Heart Network N/A
Completed NCT00284713 - Progenitor Cell Therapy in Dilative Cardiomyopathy Phase 1/Phase 2
Completed NCT01260402 - Randomized Comparison of Endocardial Versus Epicardial - From the Coronary Sinus - Left Ventricular Pacing for Resynchronization in Heart Failure. N/A
Completed NCT04192214 - The Persistence of Autoantibody Neutralisation by BC 007 in Patients With Chronic HFrEF and Autoantibodies Against the Beta1-Adrenergic Receptor Phase 2